The cell-based diagnostics company Ikonisys jumpstarted this year by receiving CLIA registration for its new clinical laboratory, located in New Haven, Connecticut. Founder and CEO Petros Tsipouras, M.D., said the company wanted to operate a CLIA lab as a way of evaluating its own diagnostic tests run on its proprietary Ikoniscope fastFISH imaging system, which was cleared by the FDA in 2006.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

April 2008 - Table of Contents

LIR April 2008 (full PDF issue)

Quest Partners With Google to Develop Portable PHR

Debt Load and Economy's Financial Crisis Put Pressure on Bostwick Labs' $100M IPO

Top 10 Lab and Pathology Tests—Surgical Path Leads With $20 Billion in Medicare Dollars

Lab Financial Benchmarks Reveal Psychemedics Tops Productivity Measures

NY Market Shift Helps Boost Bio-Reference, but DSO Benchmarks Cause Concern

Receivables, Bad Debt Could Rise as Economic Downturn Challenges Labs

Sonic Projects 20% to 25% Growth in ’08 as Federated Model and Acquisitions Pose Challenge

Ikonisys Gets CLIA Registration for Niche Reference Lab

Lab Stocks Take a Hit in March; Index Down 12% Over 5 Weeks

Stanford’s Basic Outreach Testing Unit for Sale